We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Information gathered from testing patients’ antibody neutralizing capacity “could be used in the development of COVID-19 vaccines and the screening of convalescent plasma for prophylactic and therapeutic use,” the company said. Read More